Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Rapport Therapeutics, Inc. | 558,528 | reported | 18 Feb 2026 | tx 27+1,386,647−131,000 |
| ARYA Sciences Acquisition Corp II | 114,445 | reported | 06 Feb 2023 | tx 20+820,959−192,112 |
| scPharmaceuticals Inc. | 80,971 | reported | 17 Jan 2018 | tx 1+80,971 |
| Pacira BioSciences, Inc. | 9,039 | reported | 04 Sept 2025 | tx 6+65,818−2,354 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 2,384 | reported | 08 May 2026 | tx 3+4,466 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 08 May 2026 | GRANT_AWARD | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 1,438 | 177.62 USD | |
| 18 Feb 2026 | SALE | Rapport Therapeutics, Inc. | 3,552 | 29.05 USD | |
| 18 Feb 2026 | SALE | Rapport Therapeutics, Inc. | 2,100 | 29.80 USD | |
| 18 Feb 2026 | SALE | Rapport Therapeutics, Inc. | 2,983 | 29.04 USD | |
| 18 Feb 2026 | SALE | Rapport Therapeutics, Inc. | 2,281 | 29.80 USD | |
| 02 Feb 2026 | GRANT_AWARD | Rapport Therapeutics, Inc. | 428,000 | 0.00 USD | deriv |
| 20 Jan 2026 | SALE | Rapport Therapeutics, Inc. | 5,083 | 26.11 USD | |
| 20 Jan 2026 | SALE | Rapport Therapeutics, Inc. | 5,833 | 26.12 USD | |
| 17 Dec 2025 | SALE | Rapport Therapeutics, Inc. | 2,792 | 30.04 USD | |
| 17 Dec 2025 | SALE | Rapport Therapeutics, Inc. | 515 | 31.04 USD | |
| 17 Dec 2025 | SALE | Rapport Therapeutics, Inc. | 2,421 | 30.04 USD | |
| 17 Dec 2025 | SALE | Rapport Therapeutics, Inc. | 2,441 | 28.84 USD | |
| 17 Dec 2025 | SALE | Rapport Therapeutics, Inc. | 600 | 31.04 USD | |
| 17 Dec 2025 | SALE | Rapport Therapeutics, Inc. | 2,147 | 28.84 USD | |
| 17 Nov 2025 | SALE | Rapport Therapeutics, Inc. | 2,242 | 24.91 USD | |
| 17 Nov 2025 | SALE | Rapport Therapeutics, Inc. | 3,056 | 25.43 USD | |
| 17 Nov 2025 | SALE | Rapport Therapeutics, Inc. | 2,777 | 24.92 USD | |
| 17 Nov 2025 | SALE | Rapport Therapeutics, Inc. | 2,841 | 25.44 USD | |
| 15 Oct 2025 | SALE | Rapport Therapeutics, Inc. | 1,186 | 26.14 USD | |
| 15 Oct 2025 | SALE | Rapport Therapeutics, Inc. | 4,647 | 25.72 USD | |
| 15 Oct 2025 | SALE | Rapport Therapeutics, Inc. | 4,328 | 25.75 USD | |
| 15 Oct 2025 | SALE | Rapport Therapeutics, Inc. | 755 | 26.17 USD | |
| 17 Sept 2025 | SALE | Rapport Therapeutics, Inc. | 39,435 | 26.30 USD | |
| 17 Sept 2025 | SALE | Rapport Therapeutics, Inc. | 1,400 | 26.87 USD | |
| 17 Sept 2025 | SALE | Rapport Therapeutics, Inc. | 34,885 | 26.30 USD |